You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

ORIGINAL RESEARCH article

Front. Pharmacol., 28 April 2025

Sec. Drugs Outcomes Research and Policies

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1550695

A multinational cross-sectional study on knowledge, attitudes, and practices towards magnesium supplements

  • 1. Faculty of Pharmacy, Zarqa University, Zarqa, Jordan

  • 2. Faculty of Pharmacy, Applied Science Private University, Amman, Jordan

  • 3. Clinical Pharmacy Practice, Mohammed Al-Mana College for Medical Sciences, Dammam, Saudi Arabia

  • 4. Department of Clinical Pharmacy, Faculty of Pharmacy, Al-Baha University, Al-Baha, Saudi Arabia

  • 5. Department of Clinical Pharmacy, The National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt

  • 6. Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

  • 7. Department of Medical Laboratory Sciences, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon

  • 8. Faculty of Pharmacy, Mutah University, Karak, Jordan

Article metrics

View details

4,7k

Views

2,4k

Downloads

Abstract

Background:

Magnesium is a vital mineral with a crucial role in different biochemical reactions. There is a contradicting evidences about its role in maintaining bone, muscle and cardiovascular health. Recently, magnesium supplements gained attention due to claimed effectiveness in improving sleep quality and relieving muscle spasm.

Aim:

This study aimed to assess Arab communities’ knowledge, attitudes and practices regarding magnesium supplementation.

Methods:

A cross-sectional self-administered survey was disseminated to collect responses from different Arab countries. Descriptive statistics were calculated for demographics. Data normality was assessed using Shapiro-Wilk test. Associations between sociodemographic variables and knowledge, attitudes and practices were explored using simple and multiple linear regression. Significance level was considered at p < 0.05.

Results:

A total of 1,445 responses were collected. Mean (±SD) knowledge scores were low 8.61 ± 5.9. Eighty seven percent recognized magnesium role in alleviating muscle spasm and sleep disorders (83%). Magnesium citrate was the mostly used magnesium salt (37.43%). Neutral attitudes were observed with a mean score of 3.02 ± 0.66. Only 31.8% reported using magnesium supplements, 36.1% of them received a medical consultation. Having poly cystic ovary (p = 0.033), relying on scientific articles (0.004), receiving pharmacist consultation (p = 0.019) significantly associated with higher knowledge.

Conclusion:

Despite the huge debate regarding magnesium benefits in maintaining muscle, bone health and improving sleep quality, this study found that there is a significant gap in knowledge and neutral attitude towards magnesium supplementation in Arab communities. These findings emphasizes the need for educational campaigns targeting the public on the rationale use of supplements.

Introduction

The global dietary supplement market is expanding at an exponential rate. Data from the National Health and Nutrition Examination Survey (NHNES) indicates that since the 1970s, interest in it has grown (Mahdavi-Roshan et al., 2021; Lam et al., 2022). In a study conducted in 2022 in six-Arabic speaking countries, around two thirds of the participants revealed that they used supplements (Amer et al., 2024). Similarly, a similar prevalence was also reported in a study conducted in Saudi Arabia (Syed et al., 2022). In a cross-sectional study also form Saudi Arabia, magnesium was one of the supplements found to be consumed by almost 30% of the participants (Alhashem et al., 2022).

The risk of several chronic conditions, including metabolic syndrome and cardiovascular disease, as well as certain cancers (esophageal, prostate, and colon) and overall mortality, has been linked to low magnesium intakes combined with high calcium intakes and high calcium-to-magnesium intake ratios (Costello et al., 2021).

Magnesium is the fourth most abundant mineral in the human body. It is predominately found intracellularly in bone tissues and other organs and only small amounts of around 1% is found in blood (Beckstrand and Pickens, 2011).

Magnesium is an essential ion that plays an important role in supporting and sustaining human health, as it is involved in hundreds of enzymatic reactions responsible for metabolism as well as energy production and protein synthesis (De Baaij et al., 2015). It was demonstrated that magnesium is essential for various physiological functions particularly in the skeletal muscles, heart and brain (De Baaij et al., 2015; Faryadi, 2012).

Metabolism of magnesium was reported to change with aging as its absorption via the intestine gets impaired and its renal elimination increases leading to deficiency (Barbagallo et al., 2021). It was also reported that many chronic diseases were associated with magnesium deficiency, including type-2 diabetes, many cardiovascular disorders such as stroke and hypertension as well as airway constrictive syndromes, muscle diseases, bone fragility, cancer in addition to stress-related conditions (Barbagallo et al., 2021).

Magnesium supplementation was found to probably be beneficial in individuals who suffer from hypomagnesemia, elderly and alcoholics (Wang et al., 2017). A systematic review found that magnesium supplementation reduced insulin resistance in patients who also suffer from hypomagnesemia (Morais et al., 2017). In another systematic review conducted to evaluate magnesium supplementation in individuals suffering from subjective anxiety and stress found an evidence indicating suggestive benefits of magnesium supplementation in vulnerable samples (Boyle et al., 2017). Positive evidence on the benefits of magnesium intake in reducing muscle soreness, rating of perceived exertion, and improved perceived recovery was also reported by Alyssum et al. (2022). Magnesium may also have protective effects against some cardiovascular diseases, may delay the progression of chronic kidney disease (Panta and Regmi, 2024), and it was found to achieve a small but clinically significant reduction in blood pressure (Kass et al., 2012). Moreover, it was found to be effective in alleviating mild-to-moderate depression (Tarleton et al., 2017).

Magnesium supplementation is generally well tolerated (Greupner et al., 2020), however a large share of the public obtain health information from non-medical sources such as the internet, social media, family and friends (El et al., 2016; AlMuammar et al., 2021), which can lead to inappropriate self-medication and worsen pre-existing health issues, emphasizing the importance of enhanced public health education (Zaidi et al., 2023). Furthermore, sociodemographic characteristics such as age and education can have a considerable impact on knowledge and attitudes toward magnesium supplementation (Shahid et al., 2022), and people with poor knowledge might be unaware of potential drug interactions that can complicate their health management (Shahid et al., 2022).

The rationale for this study is to gather demographic information and evaluate awareness of magnesium’s uses among Arab communities. In addition, to identify gaps in understanding and behavior, thus the results would help inform public health strategies and healthcare interventions to promote safe and informed magnesium use in the Arab world.

This study aims to comprehensively evaluate Arab communities' knowledge, attitudes and practices toward magnesium use, with a focus on determining how sociodemographic variables, information sources, and personal health experiences influence views and understanding. Exploring these relationships can yield insights that will help drive public health campaigns and educational initiatives focused on raising awareness of magnesium’s health benefits and potential hazards. Such activities are critical for empowering informed decision-making among individuals and improving health outcomes within communities.

Given the increasing prevalence of dietary supplements, researching community attitudes toward magnesium is both relevant and essential. This study will expand literatures that are aiming at filling knowledge gaps and increasing health literacy in dietary supplementation, ultimately promoting better health and wellbeing in Arab communities.

Ethical approval

Ethical approval for this study was obtained from the Institutional Review Board (IRB) committee at Applied Sciences University on 4 April 2024, following the submission of the study protocol and consent form (approval number: 2024-PH-11). Data collection took place from June 19th to 20th September 2024. Participants provided informed consent prior to responding and were assured that their data would remain confidential and anonymized, to be used merely for research purposes. They were also informed of their right to withdraw from the study at any time before submitting their responses. Any adult individual living in an Arab country was eligible to take part in the study.

Methodology

Questionnaire development and structure

This was a self-administered survey developed using Google® Forms and distributed to the public across Arabic speaking countries (i.e. Jordan, Egypt, Saudi Arabia, Syria, Iraq, Palestine, Lebanon, Yemen, Qatar, United Arab Emirates, Bahrain, Kuwait, Sudan, Tunis, Libya, Algeria, Morocco, Comoros, Oman, Mauritania, Somalia, Djibouti) through social media platforms (i.e. Meta platforms). This method of data collection has been widely used in recent public health and cross-sectional studies due to its accessibility, scalability, and ability to reach diverse populations across different regions (El et al., 2016; AlMuammar et al., 2021; Alyami et al., 2020). The questionnaire was developed and validated through an extensive literature review on the various indications and uses of magnesium. It is structured into four main sections. The first section collects demographic information from participants, including age, gender, monthly income (US dollars), country of residence (any of the 22 Arab countries), and the presence of chronic diseases.

The second section evaluates the knowledge of Arab communities regarding magnesium use, participants were asked whether magnesium can be taken without a prescription, its indications, side effects, and the possibility of drug interactions with commonly used medications and supplements (e.g., diazepam, paracetamol, diphenhydramine hydrochloride, orphenadrine, valerian root, vitamin C) (Simental-Mendía et al., 2016; von Luckner and Riederer, 2018; John et al., 2016; Landon and Young, 1993; De Oliveira et al., 2024; Rondanelli et al., 2021; Guerrera et al., 2009; Moretti, 2021; Knox et al., 2024). Participants were provided with pictures for the supplements and medications alongside generic names to ensure public recognition of these medications and supplements. Participants were also asked about magnesium’s use in the prevention of muscle spasms and sleep disorders.

In the third section, a five-point Likert scale; strongly agree, agree, neutral, disagree, strongly disagree was used to assess the community’s awareness of magnesium, including safety, effectiveness, long-term benefits, and its role in improving bone health, diabetes, migraine, cardiovascular disease, and premenstrual symptoms.

The final section assessed participants’ practices related to magnesium use. Only those who had used magnesium in the past 12 months proceeded to this section. Participants were asked whether they consulted a physician or had their magnesium blood levels tested before use. Additionally, the dosage, dosing frequency, and perceived benefits (rated on a scale of 1–10) were examined. Questions also covered the source of magnesium supplements, methods for verifying authenticity, the occurrence of side effects, sources of information, and other co-administered supplements (e.g. Vitamin D, Omega, Iron and Folic Acid). The complete questionnaire, along with the corresponding scores, is available in the Supplementary Appendix SA1.

Validity and reliability

The questionnaire was developed in Arabic and then translated into English by two bilingual academics who are fluent in both languages. The Arabic version of the questionnaire was distributed, and it is the official language of the target group countries. The questionnaire method was adopted as it is a widely recognized and efficient approach for assessing knowledge, attitudes, and practices in public health research (Launiala, 2009). It allows for standardized and scalable data collection across diverse and geographically dispersed populations. The original questionnaire was developed in Arabic, the official language of the targeted Arab countries, to ensure clarity, accessibility, and accurate comprehension of the content by participants from various educational backgrounds (Sousa and Rojjanasrirat, 2011; Tsang et al., 2017). Administering the survey in the native language improved response reliability and minimized the risk of misinterpretation.

Face and content validity were established through a pilot test, involving an equal sample of both the general public (n = 5) and academics (n = 5) with expertise in the field. Pilot participants were asked to provide feedback on any scientific terminology, jargon or ambiguous questions. Additionally, the academics were asked to review the structure and content to ensure comprehensive coverage of all relevant topics. Examples of the feedback received include separating questions on sleep disorders and muscle spasms into two discrete items, adding other indications for magnesium use, and providing examples of magnesium brands that participants might have used.

The decision to adopt a self-administered survey format was based on several key considerations. First, the study was conducted across multiple Arab countries, and an online self-administered format allowed for broader geographic reach and easier access to a diverse population. Second, it ensured participant anonymity, which is crucial when assessing personal health behaviors and supplement use, and likely reduced social desirability bias. Additionally, the online format was practical and cost-effective, enabling efficient data collection from a large sample while maintaining participant convenience. Lastly, since the study focused on self-reported knowledge, attitudes, and practices, a self-administered design was deemed appropriate and consistent with established methodologies in similar multinational KAP studies.

Sample size calculation

Considering the total Arab population, estimated at 473.27 million, a minimum sample size of 385 was calculated using an online calculator (Raosoft, 2004). This was based on a 0.05 margin of error, a 95% confidence interval (CI), and a response distribution of 50%.

Scoring

Calculation of the knowledge scores was based on participants’ responses, where each correct answer was awarded 1 point, and incorrect or unsure responses were given 0 points. The overall knowledge score ranged from 0 to 34. Based on the total score, participants were categorized into three levels of knowledge: low knowledge (0–17), moderate knowledge (Greupner et al., 2020; El et al., 2016; AlMuammar et al., 2021; Zaidi et al., 2023; Shahid et al., 2022; AlMuammar et al., 2021; Simental-Mendía et al., 2016; von Luckner and Riederer, 2018; John et al., 2016; Alyami et al., 2020), and high knowledge (Landon and Young, 1993; De Oliveira et al., 2024; Rondanelli et al., 2021; Guerrera et al., 2009; Moretti, 2021; Knox et al., 2024; Launiala, 2009). Attitudes towards magnesium were measured using a Likert scale where participants responded to statements with values from 1 (strongly disagree) to 5 (strongly agree). The overall attitude score ranged from 1 to 5. Participants’ attitudes were classified as negative (1.0–2.49), neutral (2.5–3.49), or positive (3.5–5.0).

Statistical analysis

Data were exported from Google® Forms and analyzed using the Statistical Package for Social Sciences (SPSS®) version 24.0 (SPSS Inc., Chicago, IL, United States). Descriptive statistics were employed to analyze sociodemographic data. Continuous variables were summarized as means and standard deviations (SD), while categorical variables were presented as frequencies and percentages. The Shapiro-Wilk test was applied to assess the data normality. Questionnaire reliability was evaluated using Cronbach’s alpha, with a value of 0.8, indicating good internal consistency (values above 0.7 are considered acceptable).

Simple linear regression analysis was conducted to identify independent factors that might influence participants' knowledge and attitude regarding magnesium use. Variables with a p-value <0.25 in the univariate analysis were included in the multiple linear regression models. Multicollinearity between independent variables was tested by assessing tolerance values (>0.1) and Variance Inflation Factor (VIF) values (<10). No variable was excluded from the model as none showed multicollinearity. A p-value ≤0.05 was considered statistically significant for all analyses.

Results

Sociodemographic characteristics

A total of 1,470 responses were received in this study, 25 were excluded due to incompleteness. The study included 1,445 participants with a median (interquartile range (IQR)) age of 26 years (IQR ±60). The majority were female (62.8%) and single (54.3%). Participants were mainly from Jordan (30.3%), Egypt (27.2%), and Saudi Arabia (20.6%). Most participants (49.6%) had a background in medical specialties, and 57.8% reported having health insurance. A substantial proportion (45.0%) suffered from Vitamin D deficiency, and 21.5% reported having chronic diseases (Table 1).

TABLE 1

Variable n %
Gender
• Female 907 62.8
• Male 538 37.2
Marital status
• Single 784 54.3
• Married 607 42.0
• Others 54 3.7
Residencial country
• Jordan 438 30.3
• Egypt 393 27.2
• Saudi Arabia 298 20.6
• Others 316 21.9
Monthly income of the family
• Less than 300 dinars 388 26.9
• 300–700 dinars 438 30.3
• 701–1,000 dinars 279 19.3
• More than 1,000 dinars 340 23.5
The highest degree or level of education you have completed
• Secondary education (high school diploma, Tawjihi, Baccalaureate) 120 8.3
• Vocational education 57 3.9
• Intermediate education (colleges, diploma) 202 14.0
• University education (Bachelor’s degree) 826 57.2
• Postgraduate studies (Master’s, PhD) 240 16.6
Occupation (profession)
• Medical specialties (medicine, pharmacy, nursing, laboratories, etc.) 717 49.6
• Non-medical specialties (engineering, information technology, humanities, crafts, etc.) 267 18.5
• Student 207 14.3
• Retired 36 2.5
• Unemployed 196 13.6
• Other 22 1.5
Health insurance status
• Insured 835 57.8
• Uninsured 610 42.2
If you have health insurance, does it cover dietary supplements?
• Yes 140 9.7
• No 726 50.2
• Maybe 282 19.5
• Not applicable 297 20.6
Presence of chronic diseases
Do you suffer from chronic diseases?
• Yes 311 21.5
• No 1,134 78.5
If yes, what are these diseases?a
• Diabetes 61 4.2
• Hypertension 94 6.5
• Cardiovascular disease 43 3.0
• Thyroid diseases 54 3.7
• Hyperlipidemia 105 7.3
• Obesity 128 8.9
• Sports injuries (such as slipped disc) 62 4.3
• Spinal column diseases (such as herniated disc) 108 7.5
• Others 78 5.4
Do you suffer from Vitamin D deficiency?
• Yes 650 45.0
• No 410 28.4
• Unsure 385 26.6
Did you have sleeping problems in the last 6 months?
• Always 179 12.4
• Often 352 24.4
• Sometimes 539 37.3
• Rarely 246 17.0
• Never 129 8.9
Do you have muscle problems such as frequent spasms or contractions?
• Always 108 7.5
• Often 289 20.0
• Sometimes 510 35.3
• Rarely 324 22.4
• Never 214 14.8
Age (Years) Median ± IQR
26 ± 60b

Sociodemographic characteristics of study participants (n = 1,445).

a

More than one answer was allowed.

b

Median (IQR).

Knowledge of Arab communities regarding magnesium uses

In general, participants demonstrated low levels of knowledge about magnesium, with a mean knowledge score of 8.61 (±5.9) out of 34. As, the majority of participants had low knowledge (scoring 0–17). Table 2 showed that 76.5% correctly identified magnesium is not a treatment for high blood pressure, and 87.0% acknowledged the use magnesium for alleviating muscle spasms. Only 43.5% correctly recognized magnesium as a treatment for irregular heartbeat, and 21.2% knew it could be used for migraines. Side effects of magnesium such as fatigue (75.3%), headache (74.3%), and nausea and vomiting (38.8%), were commonly recognized.

TABLE 2

Question Correct answer
n %
Is it possible to use magnesium without a prescription? 664 46.0
Which of the following are indications for using magnesium?
• Irregular heartbeat 629 43.5
• Constipation 547 37.9
• Respiratory diseases 213 14.7
• Migraine 306 21.2
• Preterm labor 208 14.4
• Preeclampsia 223 15.4
• Indigestion 438 30.3
• Maintaining bone health 784 54.3
• Improving blood sugar levels 388 26.9
• Treating high blood pressure 1,106 76.5
• Alleviating muscle spasms 1,257 87.0
Is it possible to use these medications with magnesium?
• Panadol night 1,288 89.1
• Vitamin C 646 44.7
• Valium 152 10.5
• Muscle relaxants like Orphenadrine 1,084 75.0
• Valerian root 180 12.5
Is it possible to use magnesium as a preventive measure for muscle problems in the future? 1,215 84.1
Is it possible to use magnesium as a preventive measure for sleep disorders in the future? 1,200 83.0
What are the side effects of magnesium pills?
• Nausea and vomiting 561 38.8
• Diarrhea 540 37.4
• Abdominal pain 472 32.7
• Headache 1,074 74.3
• Fatigue 1,088 75.3
• Weight gain 1,024 70.9
• Dark spots on the skin 1,087 75.2
• Depression 1,042 72.1
• Pancreatitis 1,073 74.3
• Urinary tract infection 1,095 75.8
• Blurred vision 176 12.2
• Dizziness and vertigo 301 20.8
• Fainting 191 13.2
• Other 160 11.1
• No side effects 936 64.8
Knowledge Score* (Mean, STD) 8.61, 5.9

Participants’ responses for the knowledge items about magnesium (n = 1,445).

Low Knowledge: 0–17 (0%–50% of the total score), moderate knowledge: 18–27 (51%–80% of the total score), and high knowledge: 28–34 (81%–100% of the total score) (Krathwohl et al., 1964).

*

STD, standard deviation.

The primary sources of information about magnesium were the internet and websites (58.8%), followed by social media (50.6%) and pharmacists (45.1%) (Figure 1).

FIGURE 1

FIGURE 1

Source of information about magnesium used by the study participants (n = 1,445).

Attitudes of Arab communities regarding magnesium uses

The overall attitude score was 3.02 (±0.66), indicating that most participants had a neutral attitude towards magnesium. Table 3 demonstrated that 43.6% agreed or strongly agreed that magnesium helps improve bone health, 34.8% believed that magnesium is effective for improving cardiovascular health, while 25.5% agreed it helps reduce migraines. Despite these attitudes, a significant number of participants (36.8%) were neutral regarding the safety of magnesium products.

TABLE 3

Statements Strongly disagree Disagree Neutral Agree Strongly agree
n (%)
• Magnesium products are safe and can be used without fear of complications 139 (9.6) 371 (25.7) 532 (36.8) 309 (21.4) 94 (6.5)
• The effectiveness of magnesium products is guaranteed for their intended purposes 124 (8.6) 190 (13.1) 558 (36.6) 521 (36.1) 52 (3.6)
• The results of magnesium products have long-term benefits 93 (6.4) 279 (19.3) 823 (57.0) 223 (15.4) 27 (1.9)
• Magnesium products help improve bone health 140 (9.7) 174 (12.0) 471 (32.6) 543 (37.6) 117 (8.1)
• Magnesium products help control diabetes 122 (8.4) 239 (16.5) 815 (56.4) 225 (15.6) 44 (3.0)
• Magnesium products help improve cardiovascular health 125 (8.7) 180 (12.5) 638 (44.2) 426 (29.5) 76 (5.3)
• Magnesium products help reduce migraine episodes 93 (6.4) 181 (12.5) 802 (55.5) 317 (21.9) 52 (3.6)
• Magnesium products help reduce premenstrual symptoms 108 (7.5) 197 (13.6) 819 (56.7) 282 (19.5) 39 (2.7)
• Magnesium supplements help reduce anxiety attacks 113 (7.8) 150 (10.4) 718 (49.7) 404 (28.0) 60 (4.2)
Attitude Score* (Mean, STD) 3.02, 0.66

Participants’ responses for the attitude statements about magnesium (n = 1,445).

Negative attitude scores between 1.0 and 2.49, neutral attitude (2.5–3.49), and positive attitude (3.5–5.0) (Likert, 1932).

*

STD, standard deviation.

Practices of Arab communities regarding magnesium uses

In terms of practices, 59.9% of participants reported having used dietary supplements in the past 12 months, with 31.8% indicating they had used magnesium-containing products, Table 4. Among magnesium users, 36.1% had consulted a doctor before use, and only 23.7% had their magnesium levels checked prior to supplement use.

TABLE 4

Question n %
Have you used any dietary supplements in the last 12 months?
• No 579 40.1
• Yes 866 59.9
Have you used any products containing magnesium in the last 12 months?
• No 985 68.2
• Yes 460 31.8
Have you consulted a doctor before using magnesium supplements?a
• No 294 63.9
• Yes 166 36.1
Have you had your magnesium levels checked in your blood before using these supplements?a
• No 351 76.3
• Yes 109 23.7
If you have used magnesium, what is the dosage (mg)? Mean, STD 306.62, 200.5
If you have used magnesium, how many times per day do you take the dose?a
• Once 372 80.9
• Twice 60 13.0
• Three times 28 6.1
On a scale from 1 (No benefit) to 10 (Benefited greatly), how would you rate the benefit of using magnesium? Mean, STD 6.0, 2.6
Where do you usually purchase magnesium supplements?a
• Pharmacy 425 92.4
• Doctor’s clinics 49 10.7
• Hospitals 71 15.4
• Facebook pages 37 8.0
• Family and friends abroad 55 12.0
• Commercial markets 46 10.0
• Other sources 52 11.3
What methods do you use to verify the source of magnesium supplements?a
• Pharmacist’s Association label 274 59.6
• Barcode 161 35.0
• Manufacturer’s name 275 59.8
• Consulting with the pharmacist 316 68.7
• Other 105 22.8
Have you experienced any side effects when using magnesium supplements?a
• No 387 84.1
• Yes 73 15.9
Do you regularly check medical information related to the supplements you use?a
• Always 210 45.7
• Often 108 23.5
• Sometimes 103 22.4
• Rarely 30 6.5
• Never 9 2.0
Do you use any other medications or dietary supplements with magnesium?a
• No 99 21.5
• Yes 361 78.5
If yes, what are these supplements?a
• Vitamin D 333 72.4
• Omega 3 229 49.8
• Iron 195 42.4
• Folic Acid 144 31.3
• Other 180 39.1

Participants’ responses to the practice questions about magnesium (n= 1,445).

a

These percentages were calculated based on the number of magnesium users in the study (n = 460).

The majority of users (80.9%) reported taking a magnesium supplement once per day, with an average dose of 306.62 mg (±200.5). A large proportion of users (92.4%) purchased their supplements from pharmacies, and 68.7% consulted with a pharmacist to verify the authenticity of the products they purchased.

Only 15.9% of participants reported experiencing side effects from magnesium supplements, with the most common side effects being nausea and diarrhea. Additionally, 45.7% regularly checked medical information related to the supplements they were using.

In Figure 2, the types of magnesium supplements used by participants were illustrated. Among the 390 respondents who provided answers to this question, the most commonly used magnesium supplement brands were Magfort (Magnesium Bis-glycinate) (31.79%) and Diasporal (magnesium citrate) (37.43%), followed by other popular brands like Jamieson (Magnesium (oxide, citrate, fumarate, malate and succinate)) (5.89%), Bio Mg (Magnesium Bis-glycinate) (5.38%), and Magnetrex (magnesium, vitamin B6, Citrus sinensis and taurine) (5.12%). Lesser-used brands included Carlson (Magnesium glycinate) (4.10%) and Sundown (Magnesium oxide) (4.61%).

FIGURE 2

FIGURE 2

Types of magnesium supplement used by the participants (Only 390 responses were received for this question, presented data are the percentages).

Factors affecting the participants’ knowledge and attitude toward magnesium

A linear regression analysis was conducted to assess the factors affecting both knowledge and attitude. Several factors were found to be significantly associated with the knowledge score, while others showed significance in predicting attitude. For knowledge, participants with polycystic ovary syndrome had significantly higher knowledge scores compared to those without the condition (β = 0.175, p = 0.033). Information sources also played a critical role in enhancing knowledge. Specifically, obtaining information from pharmacists (β = 0.188, p = 0.019), scientific articles (β = 0.247, p = 0.004), and the internet or websites (β = 0.182, p = 0.048) were all significant positive factor of higher knowledge scores. Additionally, participants who reported experiencing side effects from magnesium supplements demonstrated a significantly higher knowledge score (β = 0.281, p = 0.001), suggesting that personal health experiences may increase awareness and knowledge.

Regarding attitude, while no factors reached statistical significance at the conventional threshold (p < 0.05), certain variables showed a trend toward significance. These included country of residence (β = 0.181, p = 0.077), obesity (β = 0.205, p = 0.083), and obtaining information from nutritionists (β = −0.189, p = 0.075). Furthermore, participants who had used dietary supplements in the past 12 months showed a marginally significant association with a more positive attitude (β = 0.182, p = 0.073). Knowledge score itself also had a borderline positive association with attitude (β = 0.216, p = 0.054) (Table 5).

TABLE 5

Variable Knowledge Attitude
Beta p-value Beta p-value
• Age (years) 0.166 0.164
• Marital status −0.166 0.115
• Do you have health insurance? −0.112 0.153
• Do you suffer from Vitamin D deficiency? 0.12 0.146
• Polycystic ovary syndrome 0.175 0.033* −0.079 0.431
• Sleeping problems (last 6 months) −0.153 0.073
• Information source (Pharmacist) 0.188 0.019*
• Information source (Scientific articles) 0.247 0.004*
• Information source (Internet and websites) 0.182 0.048* −0.061 0.583
• Attitude 0.149 0.054
• Experienced side effects from magnesium supplements 0.281 0.001*
• Country of residence 0.181 0.077
• Health insurance covers dietary supplements 0.142 0.161
• Obesity 0.205 0.083
• Information source (Physician) 0.18 0.093
• Information source (Nutritionist) −0.189 0.075
• Used dietary supplements (last 12 months) 0.182 0.073
• Knowledge score 0.216 0.054

Linear regression analysis of factors affecting the knowledge and attitude toward magnesium.

*p < 0.05 indicates statistical significance.

Discussion

Public awareness regarding dietary supplements varies across different regions and demographics (AlTamimi, 2019). However, there remains lack of evidence about public awareness regarding magnesium use in the Arab regions. Considering the importance of exploring the underlying factors determining knowledge, attitudes, and practices related to magnesium supplements across different cultural contexts. This study was the first multinational cross-sectional study to explore the knowledge, attitudes, and practices of public in Arab countries regarding magnesium supplements.

The results of the present study revealed that participants demonstrated a low total knowledge score about magnesium, with a mean score of 8.61 ± 5.9 out of 34, indicating that participants have a limited understanding of magnesium-related information. The overall attitude score was 3.02 (±0.66), indicating that most participants had a neutral attitude towards magnesium. In terms of practices, 59.9% of participants reported using dietary supplements in the past 12 months, with 31.8% indicating they had used magnesium-containing products. The knowledge gab might be illustrated by the fact that magnesium supplements are widely self-prescribed as an over-the-counter (OTC) product. In-contrast, prescribed medicines are typically provided through healthcare providers who offer detailed information about the drug, including its indications, dosage, potential adverse drug reactions, and interactions (Khan et al., 2023). This is the first study to evaluate the public knowledge about magnesium supplements. Nevertheless, these findings are consistent with those of Alqrache et al., who assessed the patterns of dietary supplement use among students in Saudi Arabia, revealing a similar lack of awareness about their roles in health and disease (Alqrache et al., 2021). Similarly, Aghamohammadi et al. found significant deficiencies in nutritional knowledge among medical students in Iran, further highlighting gaps in understanding key dietary components (Dolatkhah et al., 2019). The findings are also consistent with the general lack of knowledge reported among Arab populations regarding nutritional supplement knowledge (Alahmadi and Albassam, 2023; Sharma et al., 2014; Wilson et al., 2010; Mullan et al., 2017; Alahmadi and Albassam, 2023). Despite the low overall knowledge score reported among the studied sample, the magnesium’s role in alleviating muscle spasms, as a preventive agent for muscle-related problems, and sleep disorders were highly recognized (87%, 84.1%, and 83%, respectively). This suggests that public is generally well-informed about magnesium role in these specific areas. This awareness may be due to widespread information on magnesium’s muscle-relaxing properties and its use in sports and general wellness (Souza et al., 2023). However, the study also identified a general lack of awareness regarding magnesium’s broader health benefits and its applications in some medical conditions, such as preterm labor, respiratory diseases, and preeclampsia.

In terms of knowledge about magnesium-related side effects, the recognition of side effects showed varied patterns for different side effects associated with magnesium use. While some side effects like urinary tract infections and fatigue were widely acknowledged, others such as blurred vision and fainting were less recognized. This pattern perhaps resulted from different sources of information or personal experiences (O’Donovan et al., 2019). On the contrary, the results of the regression analysis which indicated that presence of certain health problems, such as polycystic ovarian syndrome, notably was associated with increased knowledge levels.

Our study demonstrated that the primary sources of information about magnesium were the internet websites (58.8%), followed by social media (50.6%) and pharmacists (45.1%). The primary source of information was found to be a significant determinant of participants’ level of knowledge. For instance, obtaining information from pharmacists, scientific articles, and the internet/websites were all significant positive factors associated with higher knowledge scores. Generally, sources of information on dietary supplements varied greatly among previous studies in Arab regions (Mukattash et al., 2022; Alyami et al., 2020; Amer et al., 2024; Alsofyani et al., 2018). Amer et al. (2024), demonstrated that the main sources of information about dietary supplements were healthcare providers, with almost 80%, and specialized coaches, with 78.3%. Nonetheless, Alsofyani et al. reported that magazines, scientific books, and the internet were the three main sources of information (Alsofyani et al., 2018).

Collectively, the low levels of knowledge reported in the present study highlights the urgent need to plan targeted educational initiatives to enhance the public awareness about nutritional supplements. Such initiatives have been previously linked to improving public awareness about different drugs (Thong et al., 2021; Shen et al., 2021), and health conditions (Almutairi et al., 2023; Afzal et al., 2023). In this regard, pharmacists play a crucial role (Alkhawajah and Eferakeya, 1992), particularly for the areas with the low awareness levels such as magnesium use in conditions with significant knowledge gap, such as its use in obstetrics conditions and respiratory diseases.

In terms of attitude, the results of the present study revealed varying levels of confidence in the safety, and the effectiveness of magnesium supplements across different health areas. The overall attitude score was 3.02 ± 0.66, indicating neutral attitude. The areas with highest neutral responses were premenstrual symptoms 56.7% diabetes control 56.4%, and migraine episodes 55.5%. Conversely, neutral beliefs about the benefits of magnesium for bone health were only reported by 32.6% of the studied sample, indicating higher confidence levels in these areas specifically. This might be justified by the high knowledge scores in these areas. In line with this explanation the results of the regression analysis indicating that knowledge score had a positive association with attitude. These findings highlight the importance of addressing areas of uncertainty with clear evidence-based information.

In terms of practice, the substantial gap between general supplement uses 59.9% and magnesium-specific use 31.8% suggests that, while supplements are popular, magnesium is less commonly used, indicating lack of perceived necessity to magnesium. A similar pattern was recently reported in a multinational cross-sectional study in six Arab countries (Amer et al., 2024). Despite the prevalent use of vitamin C, vitamin D, iron, and zinc, other mineral supplements like magnesium and selenium were rarely utilized in significant proportion (66.8, and 84.4%, respectively) of the studied sample (Amer et al., 2024).

A concerning finding also was the low rate of pre-usage medical consultation 36.1%, and blood level testing 23.7%. The use of supplements without medical supervision, reported in the present study, reflects the globally prevalent irrational use of medicines (Shankar, 2009; Mao et al., 2015), including the Arab countries (Mhadi et al., 2023). This lack of medical oversight indicates potential risks of inappropriate supplementation, which could lead to adverse health outcomes. Another notable observation was the high rate of co-supplementation 78.5% with other products like Vitamin D, which raises potential interaction risks. For example, use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients (Drugs.com, 2024).

The present study is the first multinational study to assess Arab communities’ knowledge, attitudes and practices towards magnesium supplements. The study is strengthened by its multinational study design, and focus on magnesium supplement use specifically, along with its influential factors. The results of this study might help the health authorities to plan educational initiatives to enhance public awareness about magnesium use. Nonetheless, some limitations should be considered when interpreting the results of this study. The first notable limitation, is the small sample size. The observational study design which introduces risk of bias that may affect the reliability and validity of the findings: the use of online survey tool may introduce selection bias, and recall bias may also exist. The data used in the analysis of this study were self-reported, which might introduce reporting bias. Considering the present study surveyed participants from Arab countries only, limiting the generalizability of the findings to other cultural contexts. Thus, further similar studies are warranted in a diverse range of countries, encompassing other populations.

Conclusion

The study revealed a significant knowledge gap regarding magnesium, with participants demonstrating limited awareness of its broader health benefits and medical applications. Additionally, the substantial gap between general supplement use and magnesium-specific use suggests a lack of perceived necessity for magnesium. Our findings suggest that Arab communities also have neutral attitude towards magnesium supplements. The results of this study suggest that more emphasis should be placed on targeted educational initiatives to enhance the public awareness about nutritional supplements, particularly magnesium. The findings may help policymakers identify the knowledge gap, and the areas of uncertainty about magnesium with clear evidence-based information. Further larger studies are warranted in a diverse range of countries, are needed to confirm this finding.

Statements

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics statement

The studies involving humans were approved by the Institutional Review Board (IRB) committee at Applied Sciences University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

RaA: Conceptualization, Methodology, Supervision, Writing – original draft, Writing – review and editing. MB: Formal Analysis, Writing – original draft, Writing – review and editing. ST: Conceptualization, Writing – original draft, Writing – review and editing. HS: Resources, Validation, Writing – review and editing. MA: Methodology, Resources, Writing – original draft. ReA: Conceptualization, Writing – original draft, Writing – review and editing. DA: Conceptualization, Writing – original draft, Writing – review and editing. NM: Conceptualization, Writing – original draft, Writing – review and editing. FS: Resources, Validation, Writing – review and editing. WD: Resources, Validation, Writing – review and editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This work was generously funded by the deanship of Scientific Research at Zarqa University.

Acknowledgments

The authors acknowledge their institutions for supporting them to perform this study. Additionally, all study participants who consented to take part in this research.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Generative AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2025.1550695/full#supplementary-material

References

  • 1

    Afzal S. Khan F. U. Aqeel M. T. Ullah M. Bajwa M. Akhtar M. et al (2023). Impact of a pharmacist-led educational intervention on knowledge, attitude, and practice toward the rational use of antibiotics among healthcare workers in a secondary care hospital in Punjab, Pakistan. Front. Pharmacol.14, 1327576. 10.3389/fphar.2023.1327576

  • 2

    Alahmadi A. K. Albassam R. S. (2023). Assessment of general and sports nutrition knowledge, dietary habits, and nutrient intake of physical activity practitioners and athletes in riyadh, Saudi Arabia. Nutrients15 (20), 4353. 10.3390/nu15204353

  • 3

    Alhashem A. M. A. R. Alamri R. S. Alzhrani W. S. Alrakaf M. S. Alzaid N. A. et al (2022). Prevalence, patterns, and attitude regarding dietary supplement use in Saudi Arabia: data from 2019. PloS One17 (9), e0274412. 10.1371/journal.pone.0274412

  • 4

    Alkhawajah A. M. Eferakeya A. E. (1992). The role of pharmacists in patients' education on medication. Public Health106 (3), 231237. 10.1016/s0033-3506(05)80541-4

  • 5

    AlMuammar S. A. Noorsaeed A. S. Alafif R. A. Kamal Y. F. Daghistani G. M. (2021). The use of internet and social media for health information and its consequences among the population in Saudi Arabia. Cureus13 (9), e18338. 10.7759/cureus.18338

  • 6

    Almutairi K. S. Okmi E. A. Alnofaiei S. S. Alshamari W. K. Almutairi S. H. Alsuwailem S. I. et al (2023). The effects of health education on the awareness of antimicrobial resistance among high School students in riyadh, Saudi Arabia during 2023: a quasi-experimental study. Cureus15 (7), e41639. 10.7759/cureus.41639

  • 7

    Alqrache A. Mostafa M. Ghabrah O. Ghabrah Z. Kamal N. Ghabrah T. et al (2021). Knowledge and patterns of dietary supplement use among students attending King Abdulaziz University in Saudi Arabia: a cross-sectional study. Inq. J. Health Care Organ. Provis. Finance.58, 00469580211020882. 10.1177/00469580211020882

  • 8

    Alsofyani M. A. A. Al-Essa M. H. A. Assiri M. A. Alalwani B. M. Abuzeefa A. A. Qasim A. T. et al (2018). Prevalence of people that using multivitamins supplementation and experiencing A side effect in Saudi Arabia. Egypt. J. Hosp. Med.70 (1), 6571. 10.12816/0042963

  • 9

    AlTamimi J. Z. (2019). Awareness of the consumption of dietary supplements among students in a university in Saudi Arabia. J. Nutr. Metab.2019 (1), 4641768. 10.1155/2019/4641768

  • 10

    Alyami H. S. Orabi M. A. A. Aldhabbah F. M. Alturki H. N. Aburas W. I. Alfayez A. I. et al (2020). Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: a cross-sectional study in Saudi Arabia. Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc.28 (11), 13261332. 10.1016/j.jsps.2020.08.023

  • 11

    Alyssum R. Matt G. Lauren G. K. Eric K. N. Kelly P. Zella H. (2022). Effects of magnesium supplementation on muscle soreness and performance. J. Strength Cond. Res.36 (8), 21982203. 10.1519/JSC.0000000000003827

  • 12

    Amer S. Abdel-hameid M. Elsheikh S. Shailabi T. Douaouia L. Abuhaimed S. et al (2024). Consumption of dietary supplements and their determinants among adults in six Arabic countries: a cross-sectional survey. Egypt. J. Intern. Med.36 (1), 7017. 10.1186/s43162-024-00323-7

  • 13

    Barbagallo M. Veronese N. Dominguez L. J. (2021). Magnesium in aging, health and diseases. Nutrients13 (2), 463. 10.3390/nu13020463

  • 14

    Beckstrand R. L. Pickens J. S. (2011). Beneficial effects of magnesium supplementation. J. Evidence-Based Complementary Altern. Med.16 (3), 181189. 10.1177/2156587211401746

  • 15

    Boyle N. B. Lawton C. Dye L. (2017). The effects of magnesium supplementation on subjective anxiety and stress—a systematic review. Nutrients9 (5), 429. 10.3390/nu9050429

  • 16

    Costello R. Rosanoff A. Dai Q. Saldanha L. Potischman N. (2021). Perspective: characterization of dietary supplements containing calcium and magnesium and their respective ratio-is a rising ratio a cause for concern?Adv. Nutr.12 (2), 291297. 10.1093/advances/nmaa160

  • 17

    De Baaij J. H. Hoenderop J. G. Bindels R. J. (2015). Magnesium in man: implications for health and disease. Physiol. Rev.95, 146. 10.1152/physrev.00012.2014

  • 18

    De Oliveira L. Korkes H. Rizzo M. D. Siaulys M. M. Cordioli E. (2024). Magnesium sulfate in preeclampsia: broad indications, not only in neurological symptoms. Pregnancy Hypertens.36, 101126. 10.1016/j.preghy.2024.101126

  • 19

    Dolatkhah N. Aghamohammadi D. Farshbaf-Khalili A. Hajifaraji M. Hashemian M. Esmaeili S. (2019). Nutrition knowledge and attitude in medical students of tabriz university of medical sciences in 2017–2018. BMC Res. Notes12, 757766. 10.1186/s13104-019-4788-9

  • 20

  • 21

    El K. G. Ramadan W. Zeeni N. (2016). Herbal products and dietary supplements: a cross-sectional survey of use, attitudes, and knowledge among the Lebanese population. J. community health41, 566573. 10.1007/s10900-015-0131-0

  • 22

    Faryadi Q. (2012). The magnificent effect of magnesium to human health: a critical review. Int. J. Appl.2 (3), 118126.

  • 23

    Greupner T. Schneider I. Gellert S. Hahn A. (2020). Magnesium bioavailability and tolerability do not differ between two supplements with different release properties. J. Diet. Suppl.17 (4), 454466. 10.1080/19390211.2019.1629146

  • 24

    Guerrera M. P. Volpe S. L. Mao J. J. (2009). Therapeutic uses of magnesium. Am. Fam. physician80 (2), 157162.

  • 25

    John P. E. John C. M. James A. B. (2016). Risks and benefits of magnesium sulfate tocolysis in preterm labor (PTL). AIMS Public Health3 (2), 348356. 10.3934/publichealth.2016.2.348

  • 26

    Kass L. Weekes J. Carpenter L. (2012). Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur. J. Clin. Nutr.66 (4), 411418. 10.1038/ejcn.2012.4

  • 27

    Khan G. Haq N. Ahmad N. Nasim A. Javaid A. Saood M. et al (2023). Public awareness regarding the manufacturer provided information about medicine usage, safety, and adverse drug reactions in Balochistan, Pakistan. Front. Pharmacol.14, 1190741. 10.3389/fphar.2023.1190741

  • 28

    Knox C. Wilson M. Klinger C. M. Franklin M. Oler E. Wilson A. et al (2024). DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic acids Res.52 (D1), D1265D1275. 10.1093/nar/gkad976

  • 29

    Krathwohl D. R. Bloom B. S. Masia B. B. (1964). Taxonomy of educational objectives: the classification of educational goals.

  • 30

    Lam M. Khoshkhat P. Chamani M. Shahsavari S. Dorkoosh F. A. Rajabi A. et al (2022). In-depth multidisciplinary review of the usage, manufacturing, regulations and market of dietary supplements. J. Drug Deliv. Sci. Technol.67, 102985. 10.1016/j.jddst.2021.102985

  • 31

    Landon R. A. Young E. A. (1993). Role of magnesium in regulation of lung function. J. Am. Dietetic Assoc.93 (6), 674677. 10.1016/0002-8223(93)91675-g

  • 32

    Launiala A. (2009). How much can a KAP survey tell us about people's knowledge, attitudes and practices? Some observations from medical anthropology research on malaria in pregnancy in Malawi. Anthropol. Matters11 (1). 10.22582/am.v11i1.31

  • 33

    Likert R. (1932). A technique for the measurement of attitudes. Arch. Psychol.25, 55.

  • 34

    Mahdavi-Roshan M. Rezazadeh A. Joukar Fk Y. Naghipour M. Mansour-Ghanaei F. (2021). Dietary supplements consumption and its association with socioeconomic factors, obesity and main non-communicable chronic diseases in the north of Iran: the Persian guilan cohort study (PGCS). BMC Nutr.7, 84. 10.1186/s40795-021-00488-2

  • 35

    Mao W. Vu H. Xie Z. Chen W. Tang S. (2015). Systematic review on irrational use of medicines in China and Vietnam. PloS One10 (3), e0117710. 10.1371/journal.pone.0117710

  • 36

    Mhadi A. A. Ong S. C. Abed Y. Abu Ali K. A. (2023). Irrational use of medicine in Arab countries: findings from a systematic review of literature (2000–2019). Int. J. Pharm. Pract.31 (2), 165175. 10.1093/ijpp/riac082

  • 37

    Morais J. B. S. Severo J. S. de Alencar G. R. R. de Oliveira A. R. S. Cruz K. J. C. do Nascimento M. D. et al (2017). Effect of magnesium supplementation on insulin resistance in humans: a systematic review. Nutrition38, 5460. 10.1016/j.nut.2017.01.009

  • 38

    Moretti A. (2021). What is the role of magnesium for skeletal muscle cramps? A Cochrane Review summary with commentary. J. Musculoskelet. Neuronal Interact.21 (1), 13. 10.1002/14651858.CD009402.pub3

  • 39

    Mukattash T. L. Alkhalidy H. Alzu'bi B. Abu-Farha R. Itani R. Karout S. et al (2022). Dietary supplements intake during the second wave of COVID-19 pandemic: a multinational Middle Eastern study. Eur. J. Integr. Med.49, 102102. 10.1016/j.eujim.2022.102102

  • 40

    Mullan J. Weston K. M. Bonney A. Burns P. Mullan J. Rudd R. (2017). Consumer knowledge about over-the-counter NSAIDs: they don't know what they don't know. Aust. N. Z. J. public health41 (2), 210214. 10.1111/1753-6405.12589

  • 41

    O’Donovan B. Rodgers R. M. Cox A. R. Krska J. (2019). Use of information sources regarding medicine side effects among the general population: a cross-sectional survey. Prim. health care Res. Dev.20, e153. 10.1017/S1463423619000574

  • 42

    Panta R. Regmi S. (2024). Role of magnesium, effects of hypomagnesemia, and benefits of magnesium supplements in cardiovascular and chronic kidney diseases. Cureus16 (7), e64404. 10.7759/cureus.64404

  • 43

    Raosoft (2004). “Sample size calculator,” Raosoft. Available online at: http://www.raosoft.com/samplesize.html.

  • 44

    Rondanelli M. Faliva M. A. Tartara A. Gasparri C. Perna S. Infantino V. et al (2021). An update on magnesium and bone health. BioMetals34 (4), 715736. 10.1007/s10534-021-00305-0

  • 45

    Shahid R. Shoker M. Chu L. M. Frehlick R. Ward H. Pahwa P. (2022). Impact of low health literacy on patients’ health outcomes: a multicenter cohort study. BMC health Serv. Res.22 (1), 1148. 10.1186/s12913-022-08527-9

  • 46

    Shankar P. R. (2009). Medicines use in primary care in developing and transitional countries: fact book summarizing results from studies reported between 1990 and 2006. Bull. World Health Organ.87 (10), 804805. 10.2471/blt.09.070417

  • 47

    Sharma A. Adiga S. Knowledge M. A. (2014). Attitude and practices related to dietary supplements and micronutrients in health sciences students. J. Clin. Diagnostic Res. JCDR8 (8), Hc103. 10.7860/JCDR/2014/9329.4683

  • 48

    Shen L. James Dyar O. Sun Q. Wei X. Yang D. Sun C. et al (2021). The effectiveness of an educational intervention on knowledge, attitudes and reported practices on antibiotic use in humans and pigs: a quasi-experimental study in twelve villages in shandong province, China. Int. J. Environ. Res. Public Health18 (4), 1940. 10.3390/ijerph18041940

  • 49

    Simental-Mendía L. E. Sahebkar A. Rodríguez-Morán M. Guerrero-Romero F. (2016). A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol. Res.111, 272282. 10.1016/j.phrs.2016.06.019

  • 50

    Sousa V. D. Rojjanasrirat W. (2011). Translation, adaptation and validation of instruments or scales for use in cross‐cultural health care research: a clear and user‐friendly guideline. J. Eval. Clin. Pract.17 (2), 268274. 10.1111/j.1365-2753.2010.01434.x

  • 51

    Souza A. C. R. Vasconcelos A. R. Dias D. D. Komoni G. Name J. J. (2023). The integral role of magnesium in muscle integrity and aging: a comprehensive review. Nutrients15 (24), 5127. 10.3390/nu15245127

  • 52

    Syed W. Samarkandi O. Al Sadoun A. Bashatah A. Al-Rawi M. M A. (2022). Prevalence, beliefs, and the practice of the use of herbal and dietary supplements among adults in Saudi Arabia: an observational study. J. Health Care Organ. Provis. Finance.59, 469580221102202469580221102209. 10.1177/00469580221102202

  • 53

    Tarleton E. K. Littenberg B. MacLean C. D. Kennedy A. G. Daley C. (2017). Role of magnesium supplementation in the treatment of depression: a randomized clinical trial. PloS One12 (6), e0180067. 10.1371/journal.pone.0180067

  • 54

    Thong K. S. Chang C. T. Lee M. Lee J. C. Y. Tan H. S. Shafie A. A. (2021). Impact of targeted educational intervention towards public knowledge and perception of antibiotic use and resistance in the state of Perak, Malaysia. Antimicrob. Resist. Infect. Control10 (1), 29. 10.1186/s13756-021-00892-0

  • 55

    Tsang S. Royse C. F. Terkawi A. S. (2017). Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J. Anaesth.11, S80S89. 10.4103/sja.SJA_203_17

  • 56

    von Luckner A. Riederer F. (2018). Magnesium in migraine prophylaxis—is there an evidence-based rationale? A systematic review. Headache J. Head Face Pain58 (2), 199209. 10.1111/head.13217

  • 57

    Wang R. Chen C. Liu W. Zhou T. Xun P. He K. et al (2017). The effect of magnesium supplementation on muscle fitness: a meta-analysis and systematic review. Magnesium Res.30 (4), 120132. 10.1684/mrh.2018.0430

  • 58

    Wilson K. M. Singh P. Blumkin A. K. Dallas L. Klein J. D. (2010). Knowledge gaps and misconceptions about over-the-counter analgesics among adolescents attending a hospital-based clinic. Acad. Pediatr.10 (4), 228232. 10.1016/j.acap.2010.04.002

  • 59

    Zaidi S. F. Hakami A. Y. Khan M. A. Khalid A. A. Haneef A. K. Natto S. S. et al (2023). The awareness and practice of self-medication among the general public in Jeddah and Makkah. Cureus15 (5), e39706. 10.7759/cureus.39706

Summary

Keywords

magnesium salts, muscle relaxants, spasm, insomnia, magnesium supplements, over the counter, bone health, migraine

Citation

Abutaima R, Barakat M, Thiab S, Sawan HM, Amer M, Alzayer R, Abdelaziz DH, Mansour NO, Saleh F and Dayyih WA (2025) A multinational cross-sectional study on knowledge, attitudes, and practices towards magnesium supplements. Front. Pharmacol. 16:1550695. doi: 10.3389/fphar.2025.1550695

Received

23 December 2024

Accepted

15 April 2025

Published

28 April 2025

Volume

16 - 2025

Edited by

Robert L. Lins, Independent Researcher, Antwerp, Belgium

Reviewed by

Josipa Bukić, University of Split, Croatia

Oluwaseun Fapohunda, University of Arizona, United States

Updates

Copyright

*Correspondence: Rana Abutaima,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics